We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Biomarkers – Webinars and Online Events

Discover Lipid Biomarkers for Parkinson’s Disease Using MS content piece image
Webinar

Discover Lipid Biomarkers for Parkinson’s Disease Using MS

On-Demand
In this webinar, Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.
Streamlining Protein Extraction for Proteomics and Beyond content piece image
Webinar

Streamlining Protein Extraction for Proteomics and Beyond

On-Demand
During this webinar, you will discover ways to improve your protein extraction, such as by reducing workflow complexity, improving results from scarce samples, setting up robust assays and working with large sample cohorts.
Speed, Scale, Specificity: How Next-Generation Mass Spectrometry is Transforming Small Molecule Biomarker Profiling content piece image
Webinar

Speed, Scale, Specificity: How Next-Generation Mass Spectrometry is Transforming Small Molecule Biomarker Profiling

On-Demand
Speaking at Proteomics & Metabolomics 2022, Mohit Jain from Bruker, presented their talk on small molecule biomarkers in drug development.
The Most Comprehensive Insights in Cancer Genomes: Translational Research content piece image
Webinar

The Most Comprehensive Insights in Cancer Genomes: Translational Research

On-Demand
This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.

From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.

The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.
The Tumor Microenvironment Series: Overcoming Challenges in TIL Analysis content piece image
Webinar

The Tumor Microenvironment Series: Overcoming Challenges in TIL Analysis

On-Demand
Attend this webinar to:
- Overcome key challenges when working with rare antigen-specific T cells
- Learn the key considerations when preparing samples for single-cell sequencing
- Gain insights into tumor single-cell sequencing results
The Tumor Microenvironment Series: Deep Phenotyping and Biomarker Discovery content piece image
Webinar

The Tumor Microenvironment Series: Deep Phenotyping and Biomarker Discovery

On-Demand
The tumor microenvironment (TME) is a heterogenous network of various cell types and structural elements. Understanding cell interactions and biological processes within the TME offers possibilities for the development of improved and personalized therapies.

Imaging multiple biomarkers in a single tissue section combined with analysis of their spatial information within the TME enables deep phenotyping and biomarker discovery and can help improve cancer therapy.

In this webinar, we present the unique MACSima™ imaging cyclic staining (MICS) technology from Miltenyi that automates the imaging of hundreds of biomarkers and the associated software that has been specifically developed to analyze multidimensional datasets.
Predicting Drug Response Using Multiomics Data content piece image
Webinar

Predicting Drug Response Using Multiomics Data

On-Demand
Preclinical models are crucial to studying the association between molecular features of tumor cells and response to chemical perturbations. However, only a few predictors of drug responses have been successfully translated to clinical settings.
Development of a High-Volume and Robust Testing Process for Cardiovascular Assessment Using Quantitative Bottom-Up Proteomics content piece image
Webinar

Development of a High-Volume and Robust Testing Process for Cardiovascular Assessment Using Quantitative Bottom-Up Proteomics

On-Demand
Attend this webinar to learn about:
- Discover opportunities that exist in clinical research testing for protein biomarkers (particularly in cardiovascular disease)
- Learn the advantages in performing protein quantification at higher flow rates
- Understand the considerations for implementing an LC-MS analysis for protein biomarker quantification in a clinical translational context
Enabling Biomarker Discovery and Screening With FirePlex® Multiplex Assays content piece image
Webinar

Enabling Biomarker Discovery and Screening With FirePlex® Multiplex Assays

On-Demand
Multiplex assays combine several target analytes in a single reaction volume, allowing multiple biomarkers to be measured simultaneously.
Analysis of Non-Blood Body Fluids content piece image
Webinar

Analysis of Non-Blood Body Fluids

On-Demand
The best fluids for mining disease biomarkers are closest to the site of pathology. For example, rather than serum or plasma, urine is a better fluid to in patients with urinary tract diseases, and stool may be a preferred material to examine in a subject with gastrointestinal disease.
Advertisement